updated - April 19, 2019 Friday EDT
The European Commission has charged Qualcomm Incorporated with abusing its dominant position in the worldwide markets for 3G and 4G based chipsets, according to a press release issued by the Commission.
Yahoo!, Inc. will not be pushing through with its spinoff of its stake in Alibaba Group Holding Ltd., sources have told CNBC. The company would instead examine a deal that would involve its core business and its stake in Yahoo Japan.
BBCN Bancorp, Inc. has announced in a press release that it entered into an agreement with Wilshire Bancorp, Inc. to combine in a strategic merger of equals. The transaction would create the only super regional Korean-American bank in the U.S.
The Federal Trade Commission (FTC) has announced in a press release that it has filed an administrative complaint against Staple, Inc.’s proposed $6.3 billion acquisition of Office Depot, Inc., citing reduced market competition.
Ferrovial SA, one of the largest global infrastructure operators and city services managers, has announced in a press release that it has submitted an offer to acquire 100 percent of all shares of Broadspectrum Ltd for 1.35 Australian dollars per share.
CMA CGM, a French container shipping company, has announced in a press release that it will be acquiring Neptune Orient Lines (NOL). The acquisition will enable CMA CGM to reinforce its position in the container shipping industry.
Amazon.com Inc. announced in an event in Chicago that it will start rolling out thousands of Amazon-branded tractor-trailers, according to a report from Wired. The new tractor-trailers are to help make deliveries more efficient.
Avon Products Inc. is in advanced talks to sell its North American business to Cerberus Capital Management LP, a private equity firm, people familiar with the matter told The Wall Street Journal. Barington Capital Group LP, a private equity investor who led a group that collectively owns a three percent stake in Avon, warns the cosmetics maker against the transaction with Cerberus.
KaloBios Pharmaceuticals, Inc. has announced in a press release that it will be acquiring a benznidazole program from Savant Neglected Diseases, LLC, a privately-held specialty pharmaceutical company. The program is used for the treatment of Chagas Disease.
TOP 10 FRANCHISES OF 2019